Audicus Omni 2 Review

The short version

The Audicus Omni 2 is a hybrid direct-to-consumer hearing aid - self-fit OTC capability with included/optional tele-audiology support layered on top, similar in structure to Eargo and Lexie - backed by one of the strongest independent lab results in this catalog: a HearAdvisor Grade A and 4.32 out of 5 SoundScore, placing it in the top 11% of all OTC devices tested. It also comes with an unusually long 100-day risk-free trial. What keeps this from being a simple recommendation: price is a genuine, unresolved conflict across four sources, and the warranty length included standard is disputed too.

What independent testing actually found

This is a clean-proof story on the professional side, not a divergence - HearAdvisor's lab result and HearingTracker's separate editorial score both point the same direction, so we're not manufacturing tension that isn't there. But there's a real, named gap on the consumer side we're not smoothing over either.

• Professional/lab testing: HearAdvisor gives the Omni 2 a SoundGrade A and a SoundScore of 4.32 out of 5, "placing it in the top 11% of all OTC hearing aids tested" (HearAdvisor). It scores particularly well on feedback handling (4.5/5, excellent), speech-in-quiet (4.1/5), and music streaming (3.6/5) - all above HearAdvisor's category averages - with speech-in-noise as the clearer limitation (1.9/5, low in absolute terms though still above category average). HearAdvisor's own verdict: best suited to listeners who prioritize speech clarity in quieter environments and music streaming. HearingTracker separately reports its own editorial score of 4.2 out of 5, "top 60% of all products tested" (HearingTracker) - a different kind of assessment (editorial, not a lab SoundScore), not combined into the HearAdvisor figure above, but pointing the same direction.
• Consumer sentiment, separately from that lab score: we could not confirm a model-specific retailer-aggregate rating for the Omni 2. HearingTracker's own dedicated Omni 2 page shows "0 Reviews." We didn't find an Amazon listing for this model - Audicus appears to sell primarily direct rather than through major third-party retail. Trustpilot (4.4/5, 14 reviews) and Sitejabber (3.8 stars) both carry ratings for Audicus, but both are brand-wide figures covering audicus.com as a whole, not this specific model - consistent with this site's standing rule against substituting a brand-wide badge for a model-specific figure, we're not using either one here. If a specific product's customer reviews matter to your decision, we'd recommend checking Audicus's own site directly for now.

Trial period and warranty

Audicus offers a 100-day risk-free trial - notably longer than most of this catalog's 45-day norm - confirmed on the brand's own site and independently by treblehealth.com.

Warranty length is a genuine disagreement we're presenting rather than resolving: aggregated sourcing describes a 2-year standard warranty with an optional "Audicus Protect" 3-year extended-coverage plan (unlimited repairs, Clean & Care, loss replacement) purchasable within 100 days, while HearingTracker separately states a 3-year general warranty with one-time loss & damage coverage included standard. It isn't clear from what we found whether the base included coverage is 2 or 3 years.

Return shipping: the customer pays it. Audicus's own returns page states products are covered by a money-back guarantee "less return shipping fees," and expedited shipping purchased at checkout is separately non-refundable; for international orders, Audicus won't cover shipping/customs costs on a return either. (Worth flagging: that same page also referenced a "45 day money back guarantee" in the same breath, which doesn't match the 100-day trial length confirmed elsewhere on Audicus's own site - we haven't been able to reconcile that discrepancy, so treat the exact trial window as worth double-checking directly with Audicus before you buy.)

A single ear can be bought on its own - Audicus's product page explicitly offers "Left / Right / Both (+$49)" as purchase options. We couldn't confirm whether a mid-trial exchange (swapping to a different Audicus model within the trial window) is offered - see "What we couldn't confirm" below.

Fitting and hardware: it's an FDA-regulated, self-fitting OTC hearing aid, app-controlled, with no audiologist visit required for basic setup - though Audicus also includes optional tele-audiology remote-adjustment support that's commonly used on top of self-fitting, the same hybrid structure this catalog already documents for Eargo and Lexie. It's available in both disposable (size 312) and rechargeable versions, with the rechargeable option costing $50 more per ear; the rechargeable battery runs up to 16 hours per charge (3-5 hours to fully recharge), while the disposable option lasts about a week between changes. It has Bluetooth streaming and hands-free calling for both Apple and Android, with dual active connections (up to 2 devices at once). Water/dust resistance is rated IP68 (resistant to sweat, rain, and dust; not fully waterproof or submersible). It does not include a dedicated tinnitus-masking feature - Audicus states this plainly rather than leaving it ambiguous. Telecoil isn't standard, but an optional telecoil is available upon request. The companion Audicus Remote App handles volume/program/equalizer adjustments and streaming controls; it isn't stated as strictly required for the most basic operation, but it's central to normal use. The hearing-loss range covered is mild to severe - wider than the mild-to-moderate framing used by most models in this catalog, likely explained by Audicus's hybrid DTC-with-audiology-support model.

The HSA/FSA math

The Omni 2 doesn't have a single settled price - a genuine four-way conflict across sources - so here's the math at every figure we found, using pre-tax HSA or FSA dollars by marginal tax bracket. This is arithmetic, not tax advice; your actual savings depend on your specific plan and eligible-expense rules.

A fourth figure, $949, turned up in one source - but $949 × 2 = $1,898 exactly, which strongly suggests that source mislabeled a per-unit (per-ear) price as "per pair," or is reporting stale pricing. We're not treating it as a real second price point and haven't computed HSA/FSA math against it. Audicus also offers financing (e.g. 0% APR plans) and a separate "Omni 2 - Premier" membership tier, both outside the scope of this straightforward purchase-price math.

The Omni 2 is confirmed FSA/HSA/HRA-eligible, and Audicus accepts HSA/FSA cards directly at checkout on its own site. Check with your plan administrator before assuming reimbursement.

Ownership and market context

Audicus describes itself as an independent, New York-based direct-to-consumer hearing-aid company - "the first company to offer fully customizable hearing aids online," per its own 2022 press release. We haven't independently corroborated that self-description through a separate ownership registry, so we're stating it as the company's own characterization rather than an independently verified fact. We found no wind-down, discontinuation, or ownership-instability signal for Audicus - it reads as an actively operating, still-fundraising company (most recent financing news is a September 2024 debt round).

What we couldn't confirm

• Consumer/retailer rating: searched this run (Amazon, Trustpilot, Sitejabber, HearingTracker) - no model-specific figure found; only brand-wide aggregates, which we're not substituting in. See "What independent testing actually found" above.
• Mid-trial exchange policy: the only exchange-policy language we found references a "45-day money back guarantee," which conflicts with the confirmed 100-day trial length, so we can't say with confidence whether (or how) a mid-trial model swap works.

Where to buy

We haven't confirmed an affiliate relationship for Audicus. Here's a plain, no-commission link to the brand's own product page: View the Omni 2 at Audicus.

Disclosure

Drafted with AI assistance from HearingScout's verified product database; reviewed and fact-checked against primary sources before publishing. See our methodology for how we evaluate every device.